Texas Instruments Files Proxy Statement, Faces Shareholder Proposal for Written Consent Amidst Performance Concerns
Summary
Texas Instruments filed its definitive proxy statement for the April 16, 2026 annual meeting, featuring a contested shareholder proposal for written consent, which the board opposes despite prior strong shareholder support.
Key Events
-
Shareholder Proposal for Written Consent
The board opposes a shareholder proposal to permit action by written consent, citing existing robust governance. The proponent notes 78% shareholder support for this in 2021 and links it to recent company performance issues, including a Q3 earnings miss and geopolitical risks.
-
Executive Compensation Review
Shareholders will cast an advisory vote on executive compensation. CEO Haviv Ilan's total compensation for 2025 was $22.67 million, with executive bonuses increasing by 10% despite a negative 4.5% Total Shareholder Return.
-
Board Leadership Change
Richard Templeton retired as Chairman of the Board effective December 31, 2025. CEO Haviv Ilan was appointed as his successor, combining the roles of Chairman and CEO.
-
Director Elections and Auditor Ratification
The filing includes the routine election of 12 directors and the ratification of Ernst & Young LLP as the independent registered public accounting firm for 2026.
Analysis
This definitive proxy statement outlines the agenda for the upcoming annual meeting, including the election of directors, advisory vote on executive compensation, and auditor ratification. The most significant item is a shareholder proposal advocating for the right to act by written consent, which the board opposes. The proponent highlights recent company challenges, such as a Q3 earnings miss, potential layoffs, a China anti-dumping investigation, and concerns over dividend sustainability, arguing for increased shareholder power. This proposal previously garnered substantial shareholder support (78%) in 2021, indicating a persistent governance concern that could lead to further shareholder activism.
At the time of this filing, TXN was trading at $203.57 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $184.8B. The 52-week trading range was $139.95 to $231.32. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.